Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Kurkijarvi Kalevi, Director. Officer active across 1 company, notably FIBROGEN INC. Cumulatively, 2 reports have been published. Activity tracked since 26 May 2021. The latest transaction was filed on 26 May 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Kalevi Kurkijarvi is a Director at FibroGen Inc. He plays a key role in the governance of the company, bringing his expertise in biotechnology and research. As a board member, Kalevi participates in strategic decision-making that influences the company's performance and direction. His experience in the sector enables him to contribute to discussions on innovation and the development of new treatments, thereby strengthening the company's market position.